NEWS IN BRIEF

Biologics CDMO completes €5m expansion in Spain

By Staff Reporter

- Last updated on GMT

(Image: Getty/ilbusca)
(Image: Getty/ilbusca)

Related tags: Contract manufacturing organisation, Spain

Biologics and cell therapy CDMO, 3P Biopharmaceuticals, has expanded its facility and capabilities in Pamplona, Spain.

The €5m ($5.6m) project has seen 3P Biopharmaceuticals expand its good manufacturing practice (GMP) bacteria area, and install a 50L single-use bioreactor for mammalian cell culture within the facility.

“This provides an attractive option for small batch manufacture as well as for intermediate cell expansion,” ​according to the firm.

The Spanish Agency of Medicines and Medical Devices has GMP-certified the new facilities.

3P has also adopted Sartorius Stedim Biotech’s ambr 250, a single-use multi-parallel bioreactor, which it said enables the development of 24 different experiments concurrently: “This capacity facilitates rapid decision-making for future manufacturing processes.”

“Furthermore, this technology strengthens the capacity of 3P to carry our process characterisation activities – an essential phase to drive the drug to market,” ​the firm added.

The contract development and manufacturing organisation (CDMO) has hired more than 50 staff members this year, and expects the business to expand to at least 245 by the end of 2019.

Related news

Related products

show more

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Related suppliers

Follow us

Products

View more

Webinars